Fingerprint
Dive into the research topics of 'Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
Philip A. Philip, Michelle R. Mahoney, Kyle D. Holen, Donald W. Northfelt, Henry C. Pitot, Joel Picus, Patrick J. Flynn, Charles Erlichman
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations